Abstract
The epidemiology of hepatitis C virus (HCV) infection was studied in an English teaching hospital over an 18 month period. A total of 104 HCV antibody positive patients were referred for further investigation. They were divided into those diagnosed through screening (blood donors and intravenous drug abusers) and those diagnosed for other reasons, and their mean ages, known risk factors for HCV transmission, genotypes, and liver biopsy histology were analysed. Screened patients were significantly younger than the others. No significant difference in age was found between genotypes. Most patients genotyped (69%) were genotype 1. Intravenous drug abusers had a higher proportion of subtype la, and patients who acquired HCV through blood transfusion had a higher proportion of subtype lb. Liver biopsy specimens were scored using a histological activity index for liver inflammation and fibrosis. Patients with subtype lb had significantly more severe liver disease than other genotypes when the histological activity index scores for fibrosis were analysed (p<0.05). Liver disease worsened significantly with age according to all three histological activity index scores (portal activity: p<0 01, acinar activity: p<0 001, fibrosis: p<0.0001). Liver disease worsened with increased duration of infection (p<0.002), and patients who also abused alcohol presented at a significantly younger age (cirrhosis, p<0 05, hepatocellular carcinoma, p<0.02).
(Gut 1996; 38: 269-276) Keywords: hepatitis C virus, epidemiology, genotype, blood donors.
Hepatitis C virus (HCV) was cloned and characterised in 1989, and it is now clear that it is the major cause of post transfusion hepatitis.'
HCV infection commonly results in chronic disease: at least 50% of patients develop chronic hepatitis, 20% of whom develop cirrhosis.' 2 There is also a strong association between HCV and hepatocellular carcinoma.3 4 The virus is parenterally transmitted and routes of infection include transfusions of blood and blood products, abuse of intravenous drugs, tattoos, and sexual or household transmission.5-9 Nucleic acid sequence analysis has shown that HCV is a highly variable virus, and a system for the nomenclature of HCV genotypes has been proposed that divides the virus into six main genotypes.'0 It may be that some genotypes are associated with more severe liver disease. 11 Many patients who become infected with HCV are asymptomatic for decades, and remain undiagnosed until they present with symptomatic advanced liver disease. Early diagnosis is important as treatment with alpha interferon is more likely to be successful in the asymptomatic stage before progression to cirrhosis.'2 13 Thus, a knowledge of the prevalence and natural history of asymptomatic HCV related to disease duration and HCV genotypes has profound health care implications for resource allocation, as treatment of chronic HCV with alpha interferon or liver transplantation is very expensive, and is now a major factor in any health care budget. It has been estimated that the cost per year of life saved in non-cirrhotic patients with chronic HCV infection treated with interferon is $71 950.'4 Another illustration of the scale of the problem is that 97 of 426 (23%) of patients who had liver transplants performed at the University of California, San Francisco between 1988 and 1993 had chronic HCV.15
In the same study, 11 of 59 patients (1 9%) who underwent liver transplant for seronegative cryptogenic cirrhosis also developed de novo HCV infection after transplantation.
Serological diagnosis of HCV is made by screening populations such as blood donors, intravenous drug abusers, and patients who present with liver disease of unknown aetiology. The initial diagnostic test, using an enzyme linked immunosorbent assay (ELISA) to detect antibody to the C-100 antigen, was found to generate a high frequency of false positives and false negatives.'6 This obviously presented serious diagnostic problems in a disease that could remain asymptomatic for decades. Second generation ELISAs and confirmatory RIBA tests incorporating antigens from other regions of the HCV genome have reduced this problem. '6 We previously studied the prevalence of antibodies to HCV in different populations of patients in north east England using the first generation ELISA and RIBA tests: anti-HCV was detected in 21 of 1120 blood donors (0. 18%).17 Because of the problems discussed above with first generation anti-HCV testing, the aim of this study was to assess the population in the north east of England further by studying the epidemiology, genotypes, and liver histology of patients diagnosed as HCV positive by second and third generation assays at the Freeman Hospital, Newcastle upon Seventy five patients included in the study were biopsed. Liver biopsy specimens were available for pathological review from 68 patients (four patients who had been biopsied were HBsAg positive and were excluded from the liver biopsy study, three specimens were not available for review). The liver biopsy specimens were assessed independently by two observers (SJJ, ADB) blinded to the clinical and serological data. Cases in which there was a discrepancy in the independent scores were reviewed by the two pathologists together and a final grade agreed. The biopsy specimens were scored according to Scheuer21 for features of chronic hepatitis: * Portal/periportal activity (0 -none or minimal, 1 -portal inflammation, 2 -mild piecemeal necrosis, 3-moderate piecemeal necrosis, 4 -severe piecemeal necrosis; * Acinar activity (0 -none, 1 -inflammation but no necrosis, 2 -focal necrosis or acidophil bodies, 3 -severe focal cell damage, 4 -damage includes bridging necrosis; and * Fibrosis (0 -none, 1 -enlarged fibrotic portal tracts, 2 -periportal or portal-portal septa but intact architecture, 3 -fibrosis with architectural distortion but no obvious cirrhosis, 4 -probable or definite cirrhosis).
Results
Number of patients presenting, risk factors, mean ages, genotypes, liver biopsy histology, and associations with other hepatic and nonhepatic diseases were analysed.
NUMBERS OF PATIENTS PRESENTING AND RISK FACTORS
The distribution of the 104 patients diagnosed HCV RIBA positive during the 18 month (Fig 3) . The index scores comparing HCV subtype lb with other subtypes were tested using Wilcoxon-Mann-Whiiney rank sum test, ranking index scores from 0-4 for lb patients and comparing ranks with index scores for all other genotypes. A value for z of -1x93 was generated for the fibrosis index (p<005). Z values for portal activity and acinar activity were -1 x61 and -0.79 respectively (both not significant). Index scores were also compared with age. All three histological activity scores showed a significant correlation with age ( Fig 4A, B, C) 27 asymptomatic intravenous drug addicts were seen and most were found to have HCV related liver disease on further investigation. Some 22% nits of (six of 27) had evidence of current or previous ing the hepatitis B virus infection. This association cause problems within the lifespan that remains to these patients. Excessive alcohol consumption is also seen to accelerate disease progression. Comparison of mean ALT activities with liver histology shows no significant association except with the acinar activity score, supporting previous reports that the absolute ALT activity is a poor indicator of the degree of liver disease seen on biopsy specimen.26 39 The effect of genotype on liver disease has also been studied. It has been reported that patients with genotype lb have more severe liver disease.' The association remains controversial, and it has been postulated that patients with genotype lb tend to be older and therefore could have developed more severe liver disease due to chronicity of infection rather than genotype.'1 40 In our study, liver disease was more severe with genotype lb when the fibrosis scores from the histological activity index were analysed, and the effect was independent of age in the population studied as no significant difference in age was found between genotypes. Another possible explanation for the association of HCV genotype lb with more severe liver disease is the route of transmission. In this study, post transfusion hepatitis was associated with genotype lb, and intravenous drug abusers were more likely to have genotype 1 a. A high proportion of drug abusers also had mild liver disease (chronic hepatitis). It could be postulated that the infecting dose in post IL transfusion hepatitis is much higher than in intravenous drug abuse and this could be responsible for the more severe disease associated with genotype lb. There could of course also be an alternative pathogenetic mechanism related to HCV genotype, which is as yet undefined. The severe liver disease associated with genotype 1, in particular type lb, has previously been documented, together with a reduced response rate to alpha interferon. 1 1114 The response to alpha interferon was not analysed in this study because the number of patients within the group who have completed alpha interferon treatment was too small for statistical purposes. In summary, our study of a predominantly British born white patient group indicates that a significant proportion of asymptomatic HCV positive individuals diagnosed by screening have liver disease. The severity of disease may be influenced by HCV genotype. Our results suggest that chronic infection of at least 20 years is required before presentation with symptomatic end stage liver disease, emphasising the insidious course of HCV infection and the need for effective screening of asymptomatic younger individuals. The issue of whether antiviral treatment should be offered to all asymptomatic individuals in an attempt to prevent progressive disease remains unresolved, particularly in view of results suggesting that patients with little inflammatory activity (previously termed 'chronic persistent hepatitis') may have a good prognosis.42 43 The role of HCV genotypes in disease severity also needs further investigation. Future trials of therapy should be stratified for histological activity scores and HCV genotype.
